ArticleJournal of cardiovascular imaging2025

Is early use of sodium-glucose cotransporter type 2 inhibitor (SGLT2i) necessary even in diabetic patients without cardiovascular disease: a prospective study regarding the effect of SGLT2i on left ventricular diastolic function.

Kina Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.